| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic
|
Jun 12, 2026 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
$101.00
236.54% Upside
|
· |
|
AXSM
Axsome Therapeutics
|
Jun 10, 2026 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$255.00
1.86% Upside
|
+2.3% |
|
ALKS
Alkermes
|
Jun 08, 2026 | BUY |
Strong Buy
-17.5% avg upside
34 analysts
|
$44.00
2.16% Downside
|
+6.8% |
|
LQDA
Liquidia Technologies
|
Jun 04, 2026 | BUY |
Strong Buy
-28.2% avg upside
15 analysts
|
$62.00
12.76% Downside
|
+8.6% |
|
INSM
Insmed
|
Jun 04, 2026 | BUY |
Strong Buy
+82.1% avg upside
36 analysts
|
$160.00
66.93% Upside
|
-6.2% |
|
MNKD
MannKind
|
Jun 02, 2026 | BUY |
Buy
+78.6% avg upside
22 analysts
|
$11.00
179.28% Upside
|
· |
|
XENE
Xenon
|
Jun 01, 2026 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$69.00
30.36% Upside
|
-1.9% |
|
PRAX
Praxis Precision Medicines
|
Jun 01, 2026 | HOLD |
Strong Buy
+92.1% avg upside
24 analysts
|
$323.00
14.48% Upside
|
-19.4% |
|
SVRA
Savara
|
May 22, 2026 | BUY |
Strong Buy
+58.2% avg upside
17 analysts
|
$9.00
63.72% Upside
|
· |
|
WVE
Wave Life Sciences
|
May 20, 2026 | BUY |
Strong Buy
+261.8% avg upside
28 analysts
|
$14.00
127.32% Upside
|
-0.5% |
|
KROS
Keros Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+139.8% avg upside
21 analysts
|
$20.00
87.81% Upside
|
+0.0% |
|
AMPH
Amphastar Pharmaceuticals
|
May 14, 2026 | HOLD |
Hold
+41.2% avg upside
11 analysts
|
$19.00
0.94% Upside
|
· |
|
UTHR
United Therapeutics
|
May 07, 2026 | BUY |
Buy
-19.0% avg upside
26 analysts
|
$738.00
37.52% Upside
|
-3.1% |
|
RARE
Ultragenyx Pharmaceutical
|
May 06, 2026 | BUY |
Strong Buy
+142.0% avg upside
36 analysts
|
$47.00
71.28% Upside
|
-10.9% |
|
RAPP
Rapport Therapeutics, Inc.
|
Apr 22, 2026 | BUY |
Strong Buy
+46.2% avg upside
12 analysts
|
$46.00
23.27% Upside
|
+0.2% |
|
CNTA
Centessa Pharmaceuticals
|
Apr 20, 2026 | HOLD |
Buy
-14.4% avg upside
19 analysts
|
$42.00
4.94% Upside
|
+0.9% |
|
PTCT
PTC Therapeutics
|
Apr 13, 2026 | BUY |
Buy
-1.4% avg upside
29 analysts
|
$86.00
8.95% Upside
|
+11.5% |
|
RVMD
Revolution Medicines
|
Apr 01, 2025 | BUY |
Strong Buy
-12.2% avg upside
32 analysts
|
$64.00
60.74% Downside
|
+193.4% |
|
CABA
Cabaletta Bio
|
Mar 31, 2025 | BUY |
Strong Buy
+390.0% avg upside
16 analysts
|
$13.00
357.79% Upside
|
+94.9% |
|
PGEN
Precigen
|
Mar 20, 2025 | BUY |
Buy
+404.8% avg upside
11 analysts
|
$7.00
45.23% Upside
|
+82.2% |
|
ALLO
Allogene Therapeutics
|
Mar 17, 2025 | HOLD |
Strong Buy
+662.8% avg upside
28 analysts
|
$4.00
100.08% Upside
|
+22.7% |
|
IOVA
Iovance Biotherapeutics
|
Mar 17, 2025 | BUY |
Strong Buy
+225.4% avg upside
24 analysts
|
$18.00
360.33% Upside
|
+4.0% |
|
ATRA
Atara Biotherapeutics
|
Mar 11, 2025 | HOLD |
Buy
+79.8% avg upside
18 analysts
|
$3.00
70.27% Downside
|
-5.8% |
|
FATE
Fate Therapeutics
|
Mar 06, 2025 | HOLD |
Buy
+492.3% avg upside
31 analysts
|
$3.00
43.53% Upside
|
+27.9% |
|
IRON
Disc Medicine
|
Mar 03, 2025 | BUY |
Strong Buy
+20.3% avg upside
21 analysts
|
$92.00
29.87% Upside
|
+18.5% |
|
JSPR
Jasper Therapeutics
|
Mar 02, 2025 | BUY |
Strong Buy
+6345.3% avg upside
17 analysts
|
$80.00
17560.06% Upside
|
-75.8% |
|
CRSP
Crispr Therapeutics AG
|
Feb 13, 2025 | HOLD |
Buy
+39.7% avg upside
41 analysts
|
$49.00
9.42% Downside
|
+22.0% |
|
IDYA
IDEAYA Biosciences
|
Nov 06, 2024 | BUY |
Strong Buy
+55.3% avg upside
29 analysts
|
$64.00
104.90% Upside
|
-1.8% |
|
EFTR
eFFECTOR Therapeutics
|
Apr 19, 2024 | BUY |
Strong Buy
+66249899.9% avg upside
5 analysts
|
$10.00
4999899.91% Upside
|
-100.0% |
|
DTIL
Precision BioSciences
|
Aug 16, 2023 | BUY |
Strong Buy
+250.1% avg upside
12 analysts
|
$42.00
516.74% Upside
|
-43.9% |
|
SGMO
Sangamo Therapeutics
|
Aug 10, 2023 | HOLD |
Buy
+5843.7% avg upside
16 analysts
|
$3.60
1963.03% Upside
|
-5.6% |
|
NKTR
Nektar Therapeutics
|
Mar 02, 2023 | HOLD |
Strong Buy
+16.6% avg upside
25 analysts
|
$3.00
95.10% Downside
|
-49.4% |
|
NGNE
Neurogene
|
Nov 15, 2022 | HOLD |
Buy
+55.9% avg upside
23 analysts
|
$4.50
85.75% Downside
|
+62.4% |
|
GNCAQ
Genocea Biosciences
|
Apr 29, 2022 | HOLD |
Strong Buy
+573999900.0% avg upside
10 analysts
|
$0.16
15999900.04% Upside
|
· |
|
BEAM
Beam Therapeutics
|
Feb 28, 2022 | BUY |
Strong Buy
+51.4% avg upside
25 analysts
|
$120.00
251.51% Upside
|
-48.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.